4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one structure

CAS No.: 301693-62-9

Chemical Name:: 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one

Synonyms: 4-(2,5-Difluorophenyl)-2,2-dimethyl-5-{4-(methylthio)phenyl}-3(2H)-furanone;4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one;3(2H)-Furanone, 4-(2,5-difluorophenyl)-2,2-dimethyl-5-[4-(methylthio)phenyl]-;4-(2,5-difluorophenyl)-2,2-diMethyl-5-[4-(Methylsulfanyl)phenyl]-2,3-dihydrofuran-3-one

CBNumber:: CB52536177

Molecular Formula:: C19H16F2O2S

Molecular Weight:: 346.39

MDL Number:: MFCD22570931

MOL File:: 301693-62-9.mol

Request For Quotation

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one Properties

Boiling point	449.0±45.0 °C(Predicted)
Density	1.30±0.1 g/cm3(Predicted)

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one Preparation Products And Raw materials

Raw materials

Preparation Products

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one Suppliers

Global( 2)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.	+86-21-54098501	sales@sinch.com.cn	China	11605	64
guoyungurui	18162595016	3287908757@qq.com	China	10015	58

Supplier	Advantage
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.	64
guoyungurui	58

301693-62-9(4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one)Related Search:

Vecabrutinib 4-(2,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-m-tolyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

(3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3S,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide rel-(3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

[1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3S,3'R,4'S)- 3(2H)-Furanone, 5-[4-[[(acetyloxy)methyl]thio]phenyl]-4-(3-fluorophenyl)-2,2-dimethyl- 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(4-fluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 2,2-dimethyl-5-(4-(methylthio)phenyl)-4-phenylfuran-3(2H)-one

(3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(3,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one (3R,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide

1of4

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one 4-(2,5-difluorophenyl)-2,2-diMethyl-5-[4-(Methylsulfanyl)phenyl]-2,3-dihydrofuran-3-one 4-(2,5-Difluorophenyl)-2,2-dimethyl-5-{4-(methylthio)phenyl}-3(2H)-furanone 3(2H)-Furanone, 4-(2,5-difluorophenyl)-2,2-dimethyl-5-[4-(methylthio)phenyl]- 301693-62-9 C19H16F2O2S